By Business/Source
Currency:EUR
2024/FY
Stock NameRevenueRatio
Research and Development (R&D) of pharmaceutical products in order to market them in the future49.58M100.00%
By Country/Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
France49.58M100.00%